Pershagen G. , Åkerblom G., Axelsson O., Clavensjö B., Damber L., Lagarde F., et al. Residential radon exposure and lung cancer in Sweden. N Engl J Med1994; 33: 159-64.
2.
Feychting M. , Ahlbom A.Magnetic fields and cancer in children residing near Swedish high voltage power lines. Am J Epidemiol1993; 138: 467-81.
3.
Adami HO, Sparén P., Bergström R., Holmberg L., Krusemo UB, Pontén J.Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst1989; 81: 1640-7.
4.
Stenbeck M, Rosén M, editors. Cancer survival in Sweden in 1961-1991 . Acta Oncol1995; suppl. 4.
5.
Adami HO, Pontén J., Sparén P., Bergström R., Gustafsson L., Friberg LGSurvival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening, 1960-1984. Cancer1994; 73: 140-7.
6.
Bergström R. , Sparén P., Adami HOTrends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer1999; 81: 159-66.
7.
Ericson A., Gunnarskog J., Källén B., Otterblad Olausson P.Surveillance of smoking during pregnancy in Sweden, 1983-1987. Acta Obstet Gynaecol Scand1991; 70: 111-17.
8.
Norström M-L. , Cnattingius S.Smoking habits and birthweight in two successive birth cohorts in Sweden. Early Hum Dev1994 ; 37: 195-204.
9.
Cnattingius S., Haglund B.Decreasing smoking prevalence during pregnancy in Sweden: the effect for smallfor-gestational-age birth. Am J Public Health1997; 87: 410-13.
10.
Ericson A., Källén B.Pregnancy outcome in Sweden after the Chernobyl Accident. Environ Res1994; 67: 149-59.
11.
Ekelund H., Finnström O., Gunnarskog J., Källén B., Larsson Y.: Administration of vitamin K to newborn infants and childhood cancer. Br Med J1993; 307: 89-91.
12.
Otterblad Olausson P, Cnattingius S., Haglund B.Teenage pregnancies and risk of late fetal death and infant mortality. Br J Obstet Gynaecol1999; 106: 116-21.
13.
Bergh T., Ericson A., Hillensjö T., Nygren K-G., Wennerholm.Deliveries and children born after in- vitro fertilization in Sweden 1982-1995: a retrospective cohort study. Lancet1999; 354: 1579-85.
14.
Källén B.The teratogenicity of antireheumatic drugs- what is the evidence?Scand J Rheumatol1998; 27(suppl. 107): 119-24.
15.
Ericson A., Källén B., Wiholm B-E.Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol1999; 55: 503-8.
16.
Golding J., Greenwood R., Birmingham K., Mott M.Childhood cancer, intramuscular vitamin K, and pethidine given during labour . Br Med J1992; 305: 341-6.
17.
Health in Sweden.The National Public Health Report 2001. Scand J Public Health2001; suppl. 58: 1-239.
18.
Hallqvist J. , Lundberg M., Diderichsen F., Ahlbom A.Socioeconomic differences in risk of myocardial infarction 1971-1994 in Sweden: time trends, relative risks and population attributable risks. Int J Epidemiol1998; 27: 410-15.
19.
Alfredsson L., Spetz C-L., Theorell T.Type of occupation and near-future hospitalization for myocardial infarction and some other diagnoses. Int J Epidemiol1985; 14: 378-88.
20.
Pollán M., Gustavsson P.Cancer and occupation in Sweden 1971-89. EpC Report1999: 1.
21.
Magnusson C. , Baron JA, Correia N., Bergström R., Adami HO, Persson I.Breast-cancer risk following long-term oestrogen-and oestrogen-progestin replacement therapy. Int J Cancer1999; 81: 339-44.
22.
Naessén T., Persson I., Adami HO, Bergström R., Bergkvit L.Hormone replacement therapy and the risk for first hip fracture: a prospective population-based cohort study. Ann Intern Med1990; 113: 95-103.
23.
Falkeborn M. , Persson I., Terent A., Adami HO, Lithell H., Bergström R.Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med1993; 153: 1201-9.
24.
Falkeborn M. , Persson I., Adami HO, Bergström R., Eaker E., Lithell H., et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol1992; 99: 821-8.
25.
Tibblin G., Wilhelmsen L., Werkö L.Risk factors for myocardial infarction and death due to ischaemic disease and other causes. Am J Cardiol1975; 35: 514-22.
26.
Wilhelmsen L., Rosengren A., Eriksson H., Lappas G.Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med2001; 249: 253-61.
27.
Rosén M., Spetz C-L., Hammar N.Coronary artery disease in men and women. N Engl J Med1999; 341: 1931- 2.
28.
Rosengren A., Spetz C-L., Köster M., Hammar N., Alfredsson L., Rosén M.Sex differences in survival after myocardial infarction in Sweden. Eur Heart J2001; 22: 314-22.
29.
Ringbäck Weitoft G, Gullberg A., Rosén M.Avoidable mortality among psychiatric patients . Soc Psychiatry Psychiatr Epidemiol1998; 33: 430-7.
30.
Ringbäck Weitoft G, Haglund B., Rosén M.Mortality among lone mothers in Sweden: a population study. Lancet2000; 355: 1215-19.
31.
Rosén M., Alfredsson L., Hammar N., et al. Attack rate, mortality and case fatality for acute myocardial infarction in Sweden 1987-1995. Results from the Swedish Myocardial Infarction Register. J Internal Med2000; 248: 159-64.
32.
Nyström L., Larsson L-G., Rutqvist LE, Lindgren A., et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncologica1995; 34: 145-52.
33.
Allebeck P.The revised Helsinki declaration: Good for patients? Good for public health? ScandJ Public Health2002 ; 30: 1-4.
34.
Andersson H. , Möller TRFamilial breast and ovarian cancer: a Swedish population-based study. Am J Epidemiol2000 ; 152: 1154-63.
35.
Lambe M., Hsieh C-C., Chan H-W., Ekbom A., Trichopoulos D., Adami HOParity, age at first and last birth and risk of breast cancer. A population based study in Sweden. Breast Cancer Res Treat1996; 38: 305-11.
36.
Nyström L., Rutqvist LE, Wall S., et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet1993; 341: 973-8.
37.
Blomqvist P. , Andersson RE, Granath F., Lambe MP, Ekbom A.Mortality after appendectomy in Sweden 1987-1996 . Ann Surgery2001; 233: 455-60.
